TCL Archive In Brief: NCI’s Reorganization Plan Picks Up Speed In New Bureaucracy, Could Be Approved Soon February 29, 1980
TCL Archive Von Eschenbach takes leave of absence from NCI, resigns from C-Change board. Acting FDA commissioner’s drug approval strategy rooted in unproven science. Von Eschenbach told NCI deputies he might drop in on meetings. Who’s really in charge? October 7, 2005
